Precision BioSciences, Inc. (DTIL): Net earnings per share (EPS TTM)
The rolling 12-month EPS chart correlates with the strategic engagement of Precision BioSciences (DTIL) with pharmaceutical behemoths. Negative cash flow and the current trial stage confirm the absence of current earnings, while the -1.29 level reflects the current magnitude of this metric. Meanwhile, unique patents for synthetic nucleases create high business value through the long-term licensing of genome editing technologies.
Analytical breakdowns for precisionbiosciences.com (DTIL)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Precision BioSciences|DTIL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Precision BioSciences, Inc.|DTIL - Company Debts|Debts to Book Capitalization Precision BioSciences, Inc.|DTIL - Long-Term Debt Volume|Company Short-Term Debt Precision BioSciences|Quick Liquidity precisionbiosciences.com
- earnings and multiples data:
DTIL - Net Financial Result|Projected Future Earnings Precision BioSciences|DTIL - Price to Earnings Ratio|Forward P/E Multiple Precision BioSciences|DTIL - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Precision BioSciences, Inc.|DTIL - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Precision BioSciences|DTIL - Earnings per share for the last 12 months|Quarterly EPS earnings growth precisionbiosciences.com|DTIL - Net earnings per share growth this year|Earnings growth forecast for next year Precision BioSciences
Fundamental company valuation:Precision BioSciences (DTIL)
Investors assess business resilience through the ability to generate real cash flow per common share. This indicator aggregates net income over the last four quarters, excluding the impact of one-time factors. For Precision BioSciences (DTIL), such costs are associated with the implementation of ARCUS AI platforms and the robotization of genome bioscreening. Analyzing the rolling annual earnings per share allows for tracking the efficiency of these technological investments. The price action on this chart determines the company's survival threshold.
Competitors of Precision BioSciences
TEM - Earnings per share for the last twelve months|Net earnings per share for the last four quarters qiagen.com QGEN|IONS: Net earnings per share (EPS TTM)|RGEN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Avidity|Net earnings per one share for the last twelve months CRISPR CRSP|Earnings per share for the last twelve months GeneDx Holdings Corp. (WGS)|ultragenyx.com - Earnings per share for the last 12 months|Beam Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year SRPT|Twist Bio - Net earnings per share (EPS TTM)|TXG: Earnings per share for the last twelve months|NTLA: Net earnings per share (EPS TTM)|STOK - Net earnings per share for the last four quarters|Earnings per share for the last twelve months BioLife Solutions|Net earnings per one share for the last twelve months Wave Life Sciences Ltd WVE|Earnings per share for the last twelve months Maze Tx (MAZE)|Net earnings per share for the last four quarters Sionna Corp|Net earnings per share (EPS TTM) PRME (Prime Medicine, Inc.)|TSHA - Net earnings per share for the last 12 months|uniQure - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters MeiraGTx Holdings MGTX|RGNX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Solid Corp (SLDB)|Earnings per share for the last twelve months Ocugen, Inc.|Earnings per share for the last 12 months PACB (pacb.com)|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last 12 months Design Therapeutics Inc DSGN|Net earnings per share (EPS TTM) RCKT (Rocket Pharmaceuticals Inc)|4D Molecular Corp (FDMT) - Net earnings per one share for the last twelve months|LXEO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Korro Bio, Inc. KRRO|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|Net earnings per share for the last 12 months PRQR|CDXS (Codexis Bio) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) SGMO|Net earnings per share for the last four quarters nautilus.bio|Earnings per share for the last twelve months Metagenomi MGX|Generation Bio Co - Earnings per share for the last twelve months|Boundless Bio, Inc - Net earnings per share (EPS TTM)|XCUR (Exicure, Inc.) - Earnings per share for the last 12 months|imunon.com (IMNN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months PHIO|MBIO (Mustang Bio Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) TransCode|Earnings per share for the last twelve months Bionano Genomics, Inc. (BNGO)|APDN: Earnings per one share for the last 12 months|Earnings per share for the last twelve months bluebird bio, Inc. BLUE|Earnings per share for the trailing year IPA|Omega Therapeutics, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Singular Genomics Systems, Inc.|RGLS: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Syros Pharmaceuticals, Inc|TBIO (Telesis Bio, Inc.) - Net earnings per share (EPS TTM)|traconpharma.com (TCON) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Unity Biotechnology, Inc. (UBX)
